ERAS-0015A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Sponsor:

Erasca, Inc.

Code:

NCT06983743

Conditions

Metastatic Solid Tumors

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ERAS-0015

ERAS-0015 in combination

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Erasca, Inc. on 2026-07-31.